tradingkey.logo

Pacific Biosciences of California Inc

PACB
1.760USD
-0.020-1.12%
Fechamento 11/07, 16:00ETCotações atrasadas em 15 min
531.26MValor de mercado
PerdaP/L TTM

Pacific Biosciences of California Inc

1.760
-0.020-1.12%

Mais detalhes de Pacific Biosciences of California Inc Empresa

Pacific Biosciences of California, Inc. is a life science technology company. It is engaged in designing, developing, and manufacturing advanced sequencing solutions that enable scientists and clinical researchers to resolve genetically complex problems. Its products and technology under development stem from two differentiated core technologies, which include its HiFi long-read sequencing technology and its Sequencing by Binding (SBB) short-read sequencing technology. Its products address solutions across a set of applications, including human genetics, plant and animal sciences, infectious disease and microbiology, oncology, and other emerging applications. It has developed HiFi long-read sequencing based on Single-Molecule Real-Time technology, which accurately detects the nucleotide sequence and epigenetic status of individual DNA molecules. Its Revio, Sequel, Sequel II and Sequel IIe instruments conduct, monitor, and analyze single-molecule biochemical reactions in real time.

Informações de Pacific Biosciences of California Inc

Código da empresaPACB
Nome da EmpresaPacific Biosciences of California Inc
Data de listagemOct 27, 2010
CEOMr. Christian O. Henry
Número de funcionários575
Tipo de títulosOrdinary Share
Fim do ano fiscalOct 27
Endereço1305 O'brien Drive
CidadeMENLO PARK
Bolsa de valoresNASDAQ Global Select Consolidated
PaísUnited States of America
Código postal94025
Telefone16505218000
Sitehttps://www.pacb.com/
Código da empresaPACB
Data de listagemOct 27, 2010
CEOMr. Christian O. Henry

Executivos da empresa Pacific Biosciences of California Inc

Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. Christian O. Henry
Mr. Christian O. Henry
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
696.81K
-17.96%
Mr. Marshall L. Mohr, CPA
Mr. Marshall L. Mohr, CPA
Independent Director
Independent Director
110.00K
-17.18%
Dr. John F. Milligan, Ph.D.
Dr. John F. Milligan, Ph.D.
Independent Chairman of the Board
Independent Chairman of the Board
110.00K
-17.18%
Mr. Randall S. (Randy) Livingston
Mr. Randall S. (Randy) Livingston
Independent Director
Independent Director
22.82K
--
Dr. Hannah A. Valantine, M.D.
Dr. Hannah A. Valantine, M.D.
Independent Director
Independent Director
--
--
Mr. Christopher M. (Chris) Smith
Mr. Christopher M. (Chris) Smith
Independent Director
Independent Director
--
--
Dr. Lucy Shapiro, Ph.D.
Dr. Lucy Shapiro, Ph.D.
Independent Director
Independent Director
--
-100.00%
Mr. Mark Van Oene
Mr. Mark Van Oene
Chief Operating Officer
Chief Operating Officer
--
--
Mr. Jim R. Gibson
Mr. Jim R. Gibson
Chief Financial Officer, Principal Financial Officer
Chief Financial Officer, Principal Financial Officer
--
--
Ms. Kathy P. Ordonez
Ms. Kathy P. Ordonez
Independent Director
Independent Director
--
--
Ver Mais
Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. Christian O. Henry
Mr. Christian O. Henry
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
696.81K
-17.96%
Mr. Marshall L. Mohr, CPA
Mr. Marshall L. Mohr, CPA
Independent Director
Independent Director
110.00K
-17.18%
Dr. John F. Milligan, Ph.D.
Dr. John F. Milligan, Ph.D.
Independent Chairman of the Board
Independent Chairman of the Board
110.00K
-17.18%
Mr. Randall S. (Randy) Livingston
Mr. Randall S. (Randy) Livingston
Independent Director
Independent Director
22.82K
--
Dr. Hannah A. Valantine, M.D.
Dr. Hannah A. Valantine, M.D.
Independent Director
Independent Director
--
--
Mr. Christopher M. (Chris) Smith
Mr. Christopher M. (Chris) Smith
Independent Director
Independent Director
--
--

Detalhamento da receita

Moeda: USDAtualizado em: seg, 6 de out
Moeda: USDAtualizado em: seg, 6 de out
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2020
FY2019
Por EmpresaUSD
Nome
Receita
Proporção
Consumable revenue
18.93M
47.61%
Instrument revenue
14.15M
35.58%
Service And Other
6.68M
16.81%
Por RegiãoUSD
Nome
Receita
Proporção
North America
17.69M
44.48%
Asia Pacific
12.61M
31.72%
Europe (including the Middle East and Africa)
9.47M
23.81%
Por Empresa
Por Região
Por EmpresaUSD
Nome
Receita
Proporção
Consumable revenue
18.93M
47.61%
Instrument revenue
14.15M
35.58%
Service And Other
6.68M
16.81%

Distribuição de ações

Atualizado em: qui, 6 de nov
Atualizado em: qui, 6 de nov
Investidores
Tipos de investidores
Investidores
Investidores
Proporção
ARK Investment Management LLC
10.24%
SoftBank Group Corp
6.77%
BlackRock Institutional Trust Company, N.A.
6.61%
Madrone Advisors, LLC
5.55%
The Vanguard Group, Inc.
5.43%
Outro
65.39%
Investidores
Investidores
Proporção
ARK Investment Management LLC
10.24%
SoftBank Group Corp
6.77%
BlackRock Institutional Trust Company, N.A.
6.61%
Madrone Advisors, LLC
5.55%
The Vanguard Group, Inc.
5.43%
Outro
65.39%
Tipos de investidores
Investidores
Proporção
Investment Advisor
41.95%
Investment Advisor/Hedge Fund
10.49%
Holding Company
6.81%
Individual Investor
1.17%
Hedge Fund
0.99%
Research Firm
0.90%
Bank and Trust
0.50%
Venture Capital
0.32%
Pension Fund
0.12%
Outro
36.76%

Participação acionária institucional

Atualizado em: qua, 1 de out
Atualizado em: qua, 1 de out
Período do relatório
N.º de instituições
Ações detidas
Proporção
Variação
2025Q3
566
166.98M
55.32%
-97.69M
2025Q2
600
214.62M
71.52%
-110.62M
2025Q1
629
227.30M
75.82%
-104.21M
2024Q4
625
258.31M
94.32%
-61.55M
2024Q3
618
231.32M
84.94%
-85.30M
2024Q2
629
240.26M
88.29%
-64.03M
2024Q1
637
265.38M
97.57%
-38.04M
2023Q4
643
276.71M
103.53%
-9.49M
2023Q3
631
258.82M
103.48%
-18.47M
2023Q2
639
248.61M
99.68%
-37.06M
Ver Mais

Atividade dos acionistas

Nome
Ações detidas
Proporção
Variação
Var. %
Data
ARK Investment Management LLC
36.30M
12.08%
-180.28K
-0.49%
Jun 30, 2025
SoftBank Group Corp
20.45M
6.81%
--
--
Jun 30, 2025
BlackRock Institutional Trust Company, N.A.
19.97M
6.65%
-470.54K
-2.30%
Jun 30, 2025
Madrone Advisors, LLC
16.76M
5.58%
-6.63M
-28.34%
Jun 30, 2025
The Vanguard Group, Inc.
16.02M
5.33%
-197.42K
-1.22%
Jun 30, 2025
Edmond de Rothschild Asset Management (France) S.A.
13.37M
4.45%
-8.49M
-38.84%
Jun 30, 2025
Amova Asset Management Co., Ltd.
9.22M
3.07%
-346.88K
-3.63%
Jun 30, 2025
Geode Capital Management, L.L.C.
6.72M
2.24%
+401.64K
+6.36%
Jun 30, 2025
State Street Investment Management (US)
5.75M
1.92%
-625.01K
-9.80%
Jun 30, 2025
Koss-Olinger Consulting, LLC
3.30M
1.1%
+300.00K
+10.00%
Jun 30, 2025
Ver Mais

ETFs Relacionados

Atualizado em: qui, 6 de nov
Atualizado em: qui, 6 de nov
Nome
Proporção
ARK Genomic Revolution ETF
1.2%
iShares Genomics Immunology and Healthcare ETF
0.76%
AltShares Event-Driven ETF
0.75%
Invesco NASDAQ Future Gen 200 ETF
0.47%
Global X Genomics & Biotechnology ETF
0.39%
ARK Innovation ETF
0.3%
WisdomTree BioRevolution Fund
0.3%
AXS Green Alpha ETF
0.3%
Invesco RAFI US 1500 Small-Mid ETF
0.05%
Invesco Nasdaq Biotechnology ETF
0.04%
Ver Mais
ARK Genomic Revolution ETF
Proporção1.2%
iShares Genomics Immunology and Healthcare ETF
Proporção0.76%
AltShares Event-Driven ETF
Proporção0.75%
Invesco NASDAQ Future Gen 200 ETF
Proporção0.47%
Global X Genomics & Biotechnology ETF
Proporção0.39%
ARK Innovation ETF
Proporção0.3%
WisdomTree BioRevolution Fund
Proporção0.3%
AXS Green Alpha ETF
Proporção0.3%
Invesco RAFI US 1500 Small-Mid ETF
Proporção0.05%
Invesco Nasdaq Biotechnology ETF
Proporção0.04%

Dividendo

Um total de 0.00 USD foi distribuído em dividendos nos últimos 5 anos.
Data
Dividendo
Data de registro
Data de pagamento
Data ex-dividendo
Sem dados

Desdobramento de ações

Data
Tipo
Proporção
Sem dados
Data
Tipo
Proporção
Sem dados
KeyAI